Skip to main content

#160695

HEK293-CEACAM6-Fc cell line

Cat. #160695

HEK293-CEACAM6-Fc cell line

Cat. #: 160695

Sub-type: Continuous

Unit size: 1x10^6 cells / vial

Availability: 8-10 weeks

Organism: Human

Tissue: Kidney

Model: Transgenic

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: LeukoCom

Tool Details
Target Details
Handling

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: HEK293-CEACAM6-Fc cell line
  • Alternate name: Carcinoembryonic antigen-related cell adhesion molecule 6, CD66c, Cluster of Differentiation 66c
  • Research fields: Cancer;Cell biology
  • Tool sub type: Continuous
  • Parental cell: HEK293
  • Organism: Human
  • Tissue: Kidney
  • Growth properties: Adherent
  • Model: Transgenic
  • Conditional: No
  • Description: CEACAM-6 is expressed by granulocytes and their precursors. Activation enhances surface expression by mobilizing CEACAM-6 from storage in azurophilic granules. It often shows aberrant expression in acute lymphocytic leukaemia's. CEACAM-6 is also expressed in epithelia of various organs and is upregulated in pancreatic and colon adenocarcinomas and hyperplastic polyps. Over-expression confers resistance to adhesion-related apoptosis (anoikis) in tumour cells
  • Production details: Overexpression of human CEACAM6-Fc Chimera Protein
  • Biosafety level: 1
  • Recommended controls: HEK293 parental line

Target Details

  • Target: CEACAM6

Handling

  • Format: Frozen
  • Growth medium: DMEM + 10% FBS
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice
  • Storage conditions: Liquid Nitrogen
  • Mycoplasma free: Yes

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.